ANIMAL GENETICS, published by WILEY, is a leading journal in the fields of Animal Science and Zoology, with a commendable Q1 classification for 2023, reflecting its critical role in advancing research and knowledge in animal genetics. Established in 1986, this journal has become a cornerstone for professionals, researchers, and students alike, providing a platform for innovative research that explores the genetic underpinnings of animal biology. With an ISSN of 0268-9146 and an E-ISSN of 1365-2052, it boasts a significant impact in both agricultural and biological sciences, as indicated by its ranking of #74 out of 490 in its category on Scopus, positioning it in the 85th percentile for Animal Science and Zoology. Readers can access high-quality, peer-reviewed articles that not only illuminate current advancements but also foster future research directions. While currently not an open access journal, ANIMAL GENETICS remains vital for anyone engaged in the exploration of genetics and its applications in medicine and beyond, with a continual commitment to publishing findings that shape the future of animal breeding, conservation, and genetics research.

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

GENES CHROMOSOMES & CANCER, published by Wiley, is a premier journal in the intertwined fields of cancer research and genetics. With an ISSN of 1045-2257 and an e-ISSN of 1098-2264, this journal has been a significant outlet for innovative research since its inception in 1989, continuing through to 2024. Positioned in the Q2 quartile of both Cancer Research and Genetics categories in 2023, it reflects a strong impact in the scientific community, as evidenced by its Scopus rankings—99th in Genetics and 83rd in Cancer Research. Though it does not provide open access options, GENES CHROMOSOMES & CANCER offers valuable insights that foster collaboration and discovery among researchers, professionals, and students dedicated to understanding the genetic underpinnings of cancer. With its reputable standing, this journal is a vital resource for those aspiring to contribute meaningful advancements in cancer genetics and therapeutic interventions.

GENES & GENETIC SYSTEMS, an esteemed journal published by the Genetics Society of Japan, serves as a vital platform for the dissemination of innovative research within the fields of genetics, molecular biology, and medicine. Established in 1996 and based in Mishima, Shizuoka, Japan, this journal has actively contributed to the academic community, fostering collaboration and knowledge sharing among researchers and professionals. The journal’s impact can be seen through its category quartiles, which reflect its position in Genetics, Molecular Biology, and Medicine, and while it currently ranks in Q4 in Genetics and Q3 in Medicine (miscellaneous), it is poised for growth as it continues to publish pivotal studies. With a commitment to open access, GENES & GENETIC SYSTEMS ensures that research findings are freely accessible to the global scientific community, promoting a more inclusive approach to knowledge distribution. This journal is essential for students, researchers, and professionals seeking to stay informed of advancements in genetic research and its implications for the broader field of medicine.

The Egyptian Journal of Medical Human Genetics is a distinguished Open Access journal published by SPRINGER NATURE, dedicated to advancing the field of medical human genetics. With an ISSN of 1110-8630 and an E-ISSN of 2090-2441, this journal serves as a vital platform for researchers, professionals, and students who are committed to the exploration of genetic implications on human health. Since its inception in 2010, it has become a growing repository of knowledge, significantly contributing to the discourse in clinical genetics, despite currently being ranked in the Q4 quartile of its category in 2023. The journal embraces an open access model, ensuring widespread visibility and accessibility of published research, thereby fostering collaboration and innovation in the field. The journal is not only aimed at disseminating findings but also at encouraging the dialogue around genetic research developments, making it an essential resource for anyone interested in the nuances of genetics and its impact on medicine.

HEREDITAS, published by BMC, is a distinguished Open Access journal that has been a pivotal platform for the dissemination of cutting-edge research in the fields of genetics and biomedical sciences since its inception in 1920. With an impressive history spanning over a century, HEREDITAS has maintained a strong commitment to providing unrestricted access to high-quality scientific articles, ensuring that researchers and practitioners worldwide can share their findings and insights. This journal, which operates from its headquarters in the United Kingdom, is positioned within the Q3 quartile for Genetics and Q2 for miscellaneous Medicine categories according to the 2023 metrics, reflecting its significant yet evolving role in the academic landscape. Researchers are drawn to HEREDITAS not only for its legacy but also for its impact factor and contributions to the broader understanding of hereditary processes. The journal serves as an essential resource for students, scholars, and professionals who are keen on advancing the knowledge frontiers in genetics and related disciplines. With its open access policy implemented since 2005, HEREDITAS not only champions the principle of knowledge dissemination but also plays a crucial role in fostering collaborative research efforts across the globe.

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, published by Elsevier, stands as a premier journal in the fields of Genetics and Health, Toxicology and Mutagenesis, boasting a Q1 ranking in both categories for 2023. With an impressive impact factor and rigorous peer-review process, this journal serves as a vital platform for disseminating cutting-edge research and comprehensive reviews regarding the implications of genetic mutations and related health effects. Established in the Netherlands, it has evolved from its inception in the early 1990s to become an essential resource for researchers, professionals, and students alike, facilitating advancements in the understanding of mutation research. Despite not offering an open-access model, the journal ensures a wide reach through institutional subscriptions, emphasizing its commitment to fostering scholarly dialogue and promoting significant findings within the scientific community.

Gene Reports is a prominent academic journal published by Elsevier that focuses on the rapidly evolving field of genetics. Launched in 2015, this journal serves as a pivotal platform for the dissemination of cutting-edge research, bridging the gap between basic and applied genetics studies. Although it currently holds a Q4 ranking in the Genetics category and stands at the 248th position out of 347 in Scopus rankings, its potential for growth is significant given the increasing interest in genetic research across various disciplines. With an E-ISSN of 2452-0144, Gene Reports aims to provide open access to original research articles, reviews, and short communications that advance the collective understanding of genetic mechanisms and their applications. As a publication that continues to shape the future of genetics, it is an essential resource for researchers, professionals, and students seeking to stay informed about the latest developments in this crucial field.

Frontiers in Genetics is a premier academic journal dedicated to advancing the field of genetics through high-quality, peer-reviewed research. Published by FRONTIERS MEDIA SA in Switzerland since 2010, this Open Access journal provides a platform for researchers and practitioners to disseminate innovative findings across various subfields, including clinical genetics and molecular medicine. With a notable emphasis on interdisciplinary approaches, the journal holds a strong position in the academic landscape, achieving Q2 rankings in key categories such as Genetics and Molecular Medicine in 2023. Not only does Frontiers in Genetics contribute to the scholarly dialogue by publishing impactful studies, but it also promotes accessibility to vital research, ensuring that knowledge is available to a global audience. This journal is a vital resource for researchers, professionals, and students looking to stay at the forefront of genetic discoveries and their applications, reflective of its engagement with contemporary challenges in genetics and healthcare.

European Journal of Medical Genetics, published by Elsevier, is a pivotal platform dedicated to advancing knowledge in the fields of medical genetics and its clinical applications. With an ISSN of 1769-7212 and an E-ISSN of 1878-0849, this journal fosters innovative research and insights into the genetic factors that influence human health. Ranked in the Q3 category for both Genetics and Clinical Genetics, and achieving notable recognition in Medicine (miscellaneous) with a Q2 positioning, it strives to bridge the gap between laboratory findings and clinical practice. Operating in an Open Access format, the journal aims at maximally disseminating essential findings to researchers, professionals, and students alike, ensuring that critical advances in genetics are accessible to the global medical community. With converged publication years spanning from 2005 to 2024, the journal strengthens its mission to be at the forefront of genetic research that informs clinical methodologies and fosters improved healthcare outcomes.